Our Claro product range
Claro delivers advanced gelatins for tissue engineering
ClaroTM originated in 2018 following an innovative idea developed between PB Leiner (part of Tessenderlo Group) – a leading global manufacturer of high-quality gelatins and collagen peptides – and Tessenderlo Group’s Innovation Center. PB Leiner’s expertise in gelatins ignited the breakthrough in materials for bioprinting applications: gelatin with outstanding printability in extrusion-based bioprinting. Claro was incubated at the Tessenderlo Innovation Center and supported by a cross-functional team of scientists with backgrounds in organic chemistry, biochemistry, bioengineering, and chemical engineering, as well as over 30 years of activity in the pharma segment (developing and producing active pharmaceutical ingredients). Our research and innovations count on upscaling expertise, a readily available pilot plant covering 8,100 m² (which is one of the largest in Belgium), and a dedicated electromechanical team that can design and build customized installations.
Bioprintable gels (BG) product line
Bioprintable gels for extrusion-based bioprinting
Our BG800 allows bioprinting without interruptions due to nozzle blockage. A flexible and stable structure is achieved after extrusion and after crosslinking: the perfect environment for cell proliferation and growth.
Bioprintable gels for volumetric bioprinting
Our BG101 hydrogel enables bioprinting complex hydrogel structures within seconds using the volumetric printing technology patented by Readily3D.
ClaroTM and FELIX BIOprinters ensure successful bioprinting with GelMA
Claro has joined forces with FELIXprinters to expand the commercialization of its BG product line developed for extrusion-based bioprinters. Claro will directly attend to the growing demand for printable gels by FELIXprinters. Claro is the world’s only developer of gelatin featuring tailored behavior for extrusion-based bioprinting. It can also be offered in a functionalized form. This powerful combination of material and printing technology will ensure bioprinting without interruptions and no nozzle blockage that is usually observed when printing with regular gelatin-based bioinks.
Bioprint complex hydrogel structures within seconds with Claro and Readily3D
Claro will directly attend to the growing demand for bioprinting complex hydrogel structures within seconds by using the volumetric printing technology patented by Readily3D. The powerful combination of the material science expertise provided by Claro and Readily3D’s technology will ensure reliable and efficient printing performance. Claro and Readily3D have come together to support researchers in achieving breakthroughs in tissue engineering providing the right material and technology for tissue modelling in applications ranging from cell studies to drug discovery and organ printing.